Did You Know?
In 1980, PhRMA's member companies invested $2 Billion in research and development of medicines.
Direct To Consumer Ads
Straight Talk From PhRMA's Billy Tauzin
Americans who cast their ballots don't sign into the emergency room as Republicans or Democrats. They sign in as patients. Disease is non-partisan.
Health in High Definition
In The News
Biotechnology Research Expands
With 633 Medicines in Development
As the nation combats an alarming rise in chronic diseases, the Pharmaceutical Research and Manufacturers of America released a new report on the next generation of medicines in research pipelines that offer hope to millions of patients.
> read more
With 633 Medicines in Development
As the nation combats an alarming rise in chronic diseases, the Pharmaceutical Research and Manufacturers of America released a new report on the next generation of medicines in research pipelines that offer hope to millions of patients.
> read more
America’s Pharmaceutical Research
Companies Respond to Emergencies
After disastrous storms like Hurricanes Ike and Gustav come ashore, the job of picking up the pieces and rebuilding communities is never easy. But an important part of any recovery effort is making sure that needed medicines and supplies can reach disaster victims.
> Learn More
Fueling Innovation To Be
Our Best for a Better World
Through the intellectual property system, innovations become permanent assets that all of society owns – forever. With access to this knowledge, others can build on it and create new innovations.
> Click here to read more
Our Best for a Better World
Through the intellectual property system, innovations become permanent assets that all of society owns – forever. With access to this knowledge, others can build on it and create new innovations.
> Click here to read more
R&D by Pharmaceutical Companies
Reaches New Record of $58.8 Billion
America’s pharmaceutical and biotechnology research companies invested a record $58.8 billion last year in the research and development of new life-changing medicines and vaccines – an increase of nearly $3 billion.
> Learn more
Reaches New Record of $58.8 Billion
America’s pharmaceutical and biotechnology research companies invested a record $58.8 billion last year in the research and development of new life-changing medicines and vaccines – an increase of nearly $3 billion.
> Learn more